Bank of America Merrill Lynch

Bank of America Merrill Lynch is the corporate and investment banking division of Bank of America. It provides services in mergers and acquisitions, equity and debt capital markets, lending, trading, risk management, research, and liquidity and payments management. It was formed through the combination of the corporate and investment banking activities of Bank of America and Merrill Lynch following the acquisition of the latter by the former in January 2009.

Bank of America completed the acquisition of Merrill Lynch & Co on 1 January 2009. Bank of America began rebranding all of its corporate and investment banking activities under the Bank of America Merrill Lynch name in September 2009. In April 2010, Bank of America Merrill Lynch appointed Christian Meissner as head of investment banking for Europe, Middle East and Africa. In April 2011, Bank of America Merrill Lynch integrated its corporate and investment banking operations into a single division. In October 2013, Bank of America Merrill Lynch was recognised as the Most Innovative Investment Bank of the Year in The Banker's Investment Banking Awards.

Bank of America Merrill Lynch, established in 1992 and headquartered in United States, North America., specializes in Private Equity, Early Stage Venture investments across Biotechnology, Health Care, Pharmaceutical, Medical, Financial Services, Venture Capital, Finance, Banking, Lending, Asset Management. The organization boasts a portfolio of 30 investments, with an average round size of $308.1M and 23 successful exits. Their recent investments include Vertex Pharmaceuticals, Goldman Sachs, Morgan Stanley, J.P. Morgan Securities Inc., Momentive. The highest investment round they participated in was $545.5B. Among their most notable exits are Vertex Pharmaceuticals and Goldman Sachs. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.